🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.

Service Response and Material Removal

According to the social media company, the service has removed problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at residence.

Within moments of entering one community, a seller posted contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, messages display dark colored packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly significant medical dangers”.